Benefits of AstraZeneca Vaccine Outweigh Risks, Say EMA and WHO Officials – Urging Jabs to Continue as Safety Data Reviewed 12/03/2021 Madeleine Hoecklin Both the European Medicines Agency and the World Health Organization have urged that immunizations with the Oxford/AstraZeneca COVID-19 vaccine continue – despite a decision by several European countries to suspend its use – after reports of serious blood clots among 30 of the 5 million people vaccinated – leading to at least five deaths. An […] Continue reading -> Aspirin May Help Protect Against COVID-19 Infection & Serious Disease: New Peer-Reviewed Study Suggests 10/03/2021 Editorial team A study of people taking regular, low doses of aspirin found that the aspirin users were 29% less likely than others to test positive for COVID-19, as well as being less prone to serious disease and its “long COVID” after-effects. The new peer-reviewed study, published in The FEBS Journal of the Federation of European Biochemical […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Global Group of Scientists Calls For Fresh Investigation Into Origins of SARS-CoV2 Virus 05/03/2021 Madeleine Hoecklin The WHO-convened international investigation into the origin of the SARS-CoV2 virus is too politically limited by China and lacks the mandate to yield fully independent conclusions about how the novel coronavirus emerged and infected humans, according to a group of prominent international scientists – who have called for a new, independent and “unrestricted” probe into […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> COVAX Aims to Distribute 237-million Vaccine Doses By May 02/03/2021 Sindie Mhlophe The global vaccine platform, COVAX, aims to distribute 237 million doses of the Oxford/ AstraZeneca vaccine to 142 countries by the end of May 2021, its managing partners told the media on Tuesday. Eleven million doses will be delivered this week alone, with Angola, Cambodia, Democratic Republic of Congo and Nigeria getting their vaccines on […] Continue reading -> Ghana Kicks Off COVID Global Vaccine Campaign; ‘Regrettable’ That COVAX Rollout Is 3 Months Later Than In Rich Countries 01/03/2021 Kerry Cullinan Ghana and Cote d’Ivoire have become the first countries in the world to start vaccinating their health workers against COVID-19 with a supply of doses from the WHO co-sponsored global COVAX facility. But it is “regrettable” that this milestone has come almost three months after vaccine campaigns already began in rich countries, World Health Organisation’s […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Aspirin May Help Protect Against COVID-19 Infection & Serious Disease: New Peer-Reviewed Study Suggests 10/03/2021 Editorial team A study of people taking regular, low doses of aspirin found that the aspirin users were 29% less likely than others to test positive for COVID-19, as well as being less prone to serious disease and its “long COVID” after-effects. The new peer-reviewed study, published in The FEBS Journal of the Federation of European Biochemical […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Global Group of Scientists Calls For Fresh Investigation Into Origins of SARS-CoV2 Virus 05/03/2021 Madeleine Hoecklin The WHO-convened international investigation into the origin of the SARS-CoV2 virus is too politically limited by China and lacks the mandate to yield fully independent conclusions about how the novel coronavirus emerged and infected humans, according to a group of prominent international scientists – who have called for a new, independent and “unrestricted” probe into […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> COVAX Aims to Distribute 237-million Vaccine Doses By May 02/03/2021 Sindie Mhlophe The global vaccine platform, COVAX, aims to distribute 237 million doses of the Oxford/ AstraZeneca vaccine to 142 countries by the end of May 2021, its managing partners told the media on Tuesday. Eleven million doses will be delivered this week alone, with Angola, Cambodia, Democratic Republic of Congo and Nigeria getting their vaccines on […] Continue reading -> Ghana Kicks Off COVID Global Vaccine Campaign; ‘Regrettable’ That COVAX Rollout Is 3 Months Later Than In Rich Countries 01/03/2021 Kerry Cullinan Ghana and Cote d’Ivoire have become the first countries in the world to start vaccinating their health workers against COVID-19 with a supply of doses from the WHO co-sponsored global COVAX facility. But it is “regrettable” that this milestone has come almost three months after vaccine campaigns already began in rich countries, World Health Organisation’s […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Global Group of Scientists Calls For Fresh Investigation Into Origins of SARS-CoV2 Virus 05/03/2021 Madeleine Hoecklin The WHO-convened international investigation into the origin of the SARS-CoV2 virus is too politically limited by China and lacks the mandate to yield fully independent conclusions about how the novel coronavirus emerged and infected humans, according to a group of prominent international scientists – who have called for a new, independent and “unrestricted” probe into […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> COVAX Aims to Distribute 237-million Vaccine Doses By May 02/03/2021 Sindie Mhlophe The global vaccine platform, COVAX, aims to distribute 237 million doses of the Oxford/ AstraZeneca vaccine to 142 countries by the end of May 2021, its managing partners told the media on Tuesday. Eleven million doses will be delivered this week alone, with Angola, Cambodia, Democratic Republic of Congo and Nigeria getting their vaccines on […] Continue reading -> Ghana Kicks Off COVID Global Vaccine Campaign; ‘Regrettable’ That COVAX Rollout Is 3 Months Later Than In Rich Countries 01/03/2021 Kerry Cullinan Ghana and Cote d’Ivoire have become the first countries in the world to start vaccinating their health workers against COVID-19 with a supply of doses from the WHO co-sponsored global COVAX facility. But it is “regrettable” that this milestone has come almost three months after vaccine campaigns already began in rich countries, World Health Organisation’s […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Global Group of Scientists Calls For Fresh Investigation Into Origins of SARS-CoV2 Virus 05/03/2021 Madeleine Hoecklin The WHO-convened international investigation into the origin of the SARS-CoV2 virus is too politically limited by China and lacks the mandate to yield fully independent conclusions about how the novel coronavirus emerged and infected humans, according to a group of prominent international scientists – who have called for a new, independent and “unrestricted” probe into […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> COVAX Aims to Distribute 237-million Vaccine Doses By May 02/03/2021 Sindie Mhlophe The global vaccine platform, COVAX, aims to distribute 237 million doses of the Oxford/ AstraZeneca vaccine to 142 countries by the end of May 2021, its managing partners told the media on Tuesday. Eleven million doses will be delivered this week alone, with Angola, Cambodia, Democratic Republic of Congo and Nigeria getting their vaccines on […] Continue reading -> Ghana Kicks Off COVID Global Vaccine Campaign; ‘Regrettable’ That COVAX Rollout Is 3 Months Later Than In Rich Countries 01/03/2021 Kerry Cullinan Ghana and Cote d’Ivoire have become the first countries in the world to start vaccinating their health workers against COVID-19 with a supply of doses from the WHO co-sponsored global COVAX facility. But it is “regrettable” that this milestone has come almost three months after vaccine campaigns already began in rich countries, World Health Organisation’s […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Global Group of Scientists Calls For Fresh Investigation Into Origins of SARS-CoV2 Virus 05/03/2021 Madeleine Hoecklin The WHO-convened international investigation into the origin of the SARS-CoV2 virus is too politically limited by China and lacks the mandate to yield fully independent conclusions about how the novel coronavirus emerged and infected humans, according to a group of prominent international scientists – who have called for a new, independent and “unrestricted” probe into […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> COVAX Aims to Distribute 237-million Vaccine Doses By May 02/03/2021 Sindie Mhlophe The global vaccine platform, COVAX, aims to distribute 237 million doses of the Oxford/ AstraZeneca vaccine to 142 countries by the end of May 2021, its managing partners told the media on Tuesday. Eleven million doses will be delivered this week alone, with Angola, Cambodia, Democratic Republic of Congo and Nigeria getting their vaccines on […] Continue reading -> Ghana Kicks Off COVID Global Vaccine Campaign; ‘Regrettable’ That COVAX Rollout Is 3 Months Later Than In Rich Countries 01/03/2021 Kerry Cullinan Ghana and Cote d’Ivoire have become the first countries in the world to start vaccinating their health workers against COVID-19 with a supply of doses from the WHO co-sponsored global COVAX facility. But it is “regrettable” that this milestone has come almost three months after vaccine campaigns already began in rich countries, World Health Organisation’s […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> COVAX Aims to Distribute 237-million Vaccine Doses By May 02/03/2021 Sindie Mhlophe The global vaccine platform, COVAX, aims to distribute 237 million doses of the Oxford/ AstraZeneca vaccine to 142 countries by the end of May 2021, its managing partners told the media on Tuesday. Eleven million doses will be delivered this week alone, with Angola, Cambodia, Democratic Republic of Congo and Nigeria getting their vaccines on […] Continue reading -> Ghana Kicks Off COVID Global Vaccine Campaign; ‘Regrettable’ That COVAX Rollout Is 3 Months Later Than In Rich Countries 01/03/2021 Kerry Cullinan Ghana and Cote d’Ivoire have become the first countries in the world to start vaccinating their health workers against COVID-19 with a supply of doses from the WHO co-sponsored global COVAX facility. But it is “regrettable” that this milestone has come almost three months after vaccine campaigns already began in rich countries, World Health Organisation’s […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> COVAX Aims to Distribute 237-million Vaccine Doses By May 02/03/2021 Sindie Mhlophe The global vaccine platform, COVAX, aims to distribute 237 million doses of the Oxford/ AstraZeneca vaccine to 142 countries by the end of May 2021, its managing partners told the media on Tuesday. Eleven million doses will be delivered this week alone, with Angola, Cambodia, Democratic Republic of Congo and Nigeria getting their vaccines on […] Continue reading -> Ghana Kicks Off COVID Global Vaccine Campaign; ‘Regrettable’ That COVAX Rollout Is 3 Months Later Than In Rich Countries 01/03/2021 Kerry Cullinan Ghana and Cote d’Ivoire have become the first countries in the world to start vaccinating their health workers against COVID-19 with a supply of doses from the WHO co-sponsored global COVAX facility. But it is “regrettable” that this milestone has come almost three months after vaccine campaigns already began in rich countries, World Health Organisation’s […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
COVAX Aims to Distribute 237-million Vaccine Doses By May 02/03/2021 Sindie Mhlophe The global vaccine platform, COVAX, aims to distribute 237 million doses of the Oxford/ AstraZeneca vaccine to 142 countries by the end of May 2021, its managing partners told the media on Tuesday. Eleven million doses will be delivered this week alone, with Angola, Cambodia, Democratic Republic of Congo and Nigeria getting their vaccines on […] Continue reading -> Ghana Kicks Off COVID Global Vaccine Campaign; ‘Regrettable’ That COVAX Rollout Is 3 Months Later Than In Rich Countries 01/03/2021 Kerry Cullinan Ghana and Cote d’Ivoire have become the first countries in the world to start vaccinating their health workers against COVID-19 with a supply of doses from the WHO co-sponsored global COVAX facility. But it is “regrettable” that this milestone has come almost three months after vaccine campaigns already began in rich countries, World Health Organisation’s […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Ghana Kicks Off COVID Global Vaccine Campaign; ‘Regrettable’ That COVAX Rollout Is 3 Months Later Than In Rich Countries 01/03/2021 Kerry Cullinan Ghana and Cote d’Ivoire have become the first countries in the world to start vaccinating their health workers against COVID-19 with a supply of doses from the WHO co-sponsored global COVAX facility. But it is “regrettable” that this milestone has come almost three months after vaccine campaigns already began in rich countries, World Health Organisation’s […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> Posts navigation Older postsNewer posts